KZA Media Thread, page-986

The question may not have been attributed to you directly, but James did answer the issue of the CR. Basically, the uncertainty of the global financial markets moving forward and the fact that the company wishes to be cashed up at this point necessitated the CR. Further, his view is that by having the funds in the bank, the AGILE trial can further progress further along the commercialisation path. A path further along this route means more value for shareholders should discussions with a partner or a suitor eventuate.